These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 33961413)

  • 21. Point-of-care CRISPR/Cas nucleic acid detection: Recent advances, challenges and opportunities.
    van Dongen JE; Berendsen JTW; Steenbergen RDM; Wolthuis RMF; Eijkel JCT; Segerink LI
    Biosens Bioelectron; 2020 Oct; 166():112445. PubMed ID: 32758911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutting Edge Genetics: CRISPR/Cas9 Editing of Plant Genomes.
    Soyars CL; Peterson BA; Burr CA; Nimchuk ZL
    Plant Cell Physiol; 2018 Aug; 59(8):1608-1620. PubMed ID: 29912402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in therapeutic CRISPR/Cas9 genome editing.
    Savić N; Schwank G
    Transl Res; 2016 Feb; 168():15-21. PubMed ID: 26470680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRISPR Keeps Things Fresh: Next-Generation Tools for Gene Editing.
    Flotte TR
    Hum Gene Ther; 2021 Mar; 32(5-6):235-236. PubMed ID: 33750218
    [No Abstract]   [Full Text] [Related]  

  • 25. Harnessing CRISPR-Cas systems for bacterial genome editing.
    Selle K; Barrangou R
    Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clustered Regularly Interspaced Short Palindromic Repeats/Cas9-Mediated Lateral Flow Nucleic Acid Assay.
    Wang X; Xiong E; Tian T; Cheng M; Lin W; Wang H; Zhang G; Sun J; Zhou X
    ACS Nano; 2020 Feb; 14(2):2497-2508. PubMed ID: 32045522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells.
    Zhang Y; Sastre D; Wang F
    Curr Stem Cell Res Ther; 2018; 13(4):243-251. PubMed ID: 29446747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
    Xu R; Wei P; Yang J
    Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRISPR-Cas tools to study gene function in cytokinesis.
    Husser MC; Skaik N; Martin VJJ; Piekny A
    J Cell Sci; 2021 Apr; 134(8):. PubMed ID: 33912919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clustered Regularly Interspaced short palindromic repeats-Based Microfluidic System in Infectious Diseases Diagnosis: Current Status, Challenges, and Perspectives.
    Xie Y; Li H; Chen F; Udayakumar S; Arora K; Chen H; Lan Y; Hu Q; Zhou X; Guo X; Xiu L; Yin K
    Adv Sci (Weinh); 2022 Dec; 9(34):e2204172. PubMed ID: 36257813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Recent developments in enhancing the efficiency of CRISPR/Cas9- mediated knock-in in animals].
    Li GL; Yang SX; Wu ZF; Zhang XW
    Yi Chuan; 2020 Jul; 42(7):641-656. PubMed ID: 32694104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Research progress of CRISPR-Cas9 system for gene therapy].
    Zhan C; Xia X
    Sheng Wu Gong Cheng Xue Bao; 2016 Jul; 32(7):861-869. PubMed ID: 29019208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Toolkit of CRISPR-Based Genome Editing Systems in Drosophila.
    Xu J; Ren X; Sun J; Wang X; Qiao HH; Xu BW; Liu LP; Ni JQ
    J Genet Genomics; 2015 Apr; 42(4):141-9. PubMed ID: 25953352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Survey of Validation Strategies for CRISPR-Cas9 Editing.
    Sentmanat MF; Peters ST; Florian CP; Connelly JP; Pruett-Miller SM
    Sci Rep; 2018 Jan; 8(1):888. PubMed ID: 29343825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Biology and Application Areas of CRISPR Technologies.
    Adli M
    J Mol Biol; 2019 Jan; 431(1):1-2. PubMed ID: 30447221
    [No Abstract]   [Full Text] [Related]  

  • 36. CRISPR-Cas Tools and Their Application in Genetic Engineering of Human Stem Cells and Organoids.
    Hendriks D; Clevers H; Artegiani B
    Cell Stem Cell; 2020 Nov; 27(5):705-731. PubMed ID: 33157047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
    Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
    J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of CRISPR-Cas in advancing precision periodontics.
    Barbour A; Glogauer J; Grinfeld L; Ostadsharif Memar R; Fine N; Tenenbaum H; Glogauer M
    J Periodontal Res; 2021 Jun; 56(3):454-461. PubMed ID: 33452819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Advances in gene therapy for β-thalassemia and hemophilia based on the CRISPR/Cas9 technology].
    Bao LW; Zhou YY; Zeng FY
    Yi Chuan; 2020 Oct; 42(10):949-964. PubMed ID: 33229321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assembling the Streptococcus thermophilus clustered regularly interspaced short palindromic repeats (CRISPR) array for multiplex DNA targeting.
    Guo L; Xu K; Liu Z; Zhang C; Xin Y; Zhang Z
    Anal Biochem; 2015 Jun; 478():131-3. PubMed ID: 25748774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.